Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
Results
|
Strong Performer, Getting Expensive
2019.6000
-43.20
(
-2.09
%)
NSE
Aug 08, 2025
15:31 PM
58.34% Gain from 52W Low
Volume:
297.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
22 May 2023
Results
2019.60
-2.09%
Glenmark Pharma
Hold:
Glenmark Pharmaceuticals Ltd.
by
ICICI Direct
Target: 580
Target
ICICI Direct
Number of FII/FPI investors decreased from 404 to 396 in Jun 2025 qtr
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - August 8, 2025
The Baseline |
08 Aug 2025
Market closes lower, SBI's Q1 net profit grows 12.5% YoY to Rs 19,160.4 crore
Trendlyne Marketwatch |
08 Aug 2025
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020